malondialdehyde has been researched along with Ventricular Dysfunction in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Meng, M; Yang, M; Zhao, J | 1 |
Li, SH; Wu, K; Yang, C; You, Q | 1 |
2 other study(ies) available for malondialdehyde and Ventricular Dysfunction
Article | Year |
---|---|
Etanercept attenuates myocardial ischemia/reperfusion injury by decreasing inflammation and oxidative stress.
Topics: Animals; Apoptosis; Creatine Kinase, MB Form; Disease Models, Animal; Etanercept; Gene Expression Regulation; Glutathione Peroxidase; Immunoglobulin G; Inflammation; Lactate Dehydrogenases; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Neutrophil Infiltration; Oxidative Stress; Rats; Receptors, Tumor Necrosis Factor; Superoxide Dismutase; Toll-Like Receptor 4; Troponin I; Tumor Necrosis Factor-alpha; Ventricular Dysfunction | 2014 |
Protective effect of curcumin against cardiac dysfunction in sepsis rats.
Topics: Animals; Body Temperature Regulation; Cardiac Output; Cardiotonic Agents; Cecum; Curcumin; Disease Models, Animal; Heart Rate; Ligation; Lipid Peroxidation; Male; Malondialdehyde; Myocardial Contraction; Myocardium; Punctures; Rats; Rats, Sprague-Dawley; Sepsis; Stroke Volume; Superoxide Dismutase; Troponin I; Ventricular Dysfunction; Ventricular Function | 2013 |